Bipartisan leaders of key House and Senate committees are soliciting information from experts about best practices for developing a regulatory framework for CBD.
As the Food and Drug Administration (FDA) continues face pressure to create rules so that the hemp-derived cannabinoid can be lawfully marketed as food items or dietary supplements, bipartisan lawmakers have put out a Request for Information (RFI) to gather relevant information from subject matter experts.
The chairs and ranking members of the Senate Health, Education, Labor, and Pensions (HELP) Committee and House Energy & Commerce Committee are leading the effort, inviting people to weigh in on various issues related to FDA and CBD.
Specifically, they are asking for feedback on FDA’s position that there is not a regulatory pathway that enables it to enact regulations for CBD in the food supply or as a dietary supplement, the emergence of intoxicating cannabinoids like delta-8 THC that are synthetically produced using legal CBD, how regulations should “balance consumer safety with consumer access” and information about labeling requirements.
NEW: Bicameral Health Committee leaders @FrankPallone, @cathymcmorris, @SenSanders, and @SenBillCassidy issue request for information regarding FDA regulation of CBD 👇 https://t.co/YqMhZVkRta
— Energy & Commerce Democrats (@EnergyCommerce) July 27, 2023
Read full article on Marijuana Moment
